Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Cantor Fitzgerald on Monday downgraded Tilray TLRY, -1.90% to neutral from overweight and cut the cannabis stock's 12-month price target to $11.80 a share from $18. Analyst Pablo Zuanic said the firm "has difficulty making an investment case for them based on fundamentals vs.

Cantor Fitzgerald cuts Tilray rating to neutral from overweight

Canopy Growth

SNDL Inc.

Village Farms International

Best Marijuana Stocks To Buy In Q4 2021 As top marijuana stocks… The post Top Canadian Cannabis Stocks To Buy In November? 4 To Add To Your List Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Cannabis Stocks To Buy In November? 4 To Add To Your List Right Now

Aurora Cannabis

Agrify

Turning Point Brands

Valley National

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

Cannabis Stocks in Focus This week

TLRY stock has plummeted since it was pumped to $67 in February. Tilray is one of the few meme stocks investors should be buying on the dip.

TLRY Stock: Why Meme Traders Should Buy the Dip In Tilray

Cronos Group

Canaccord Genuity Corp released its cannabis market report indicating a 26% increase in revenue opportunities for US businesses, reaching up to $30 billion in revenue in 2022. The report also outlines a compelling value proposition for Multi-State-Operators (MSOs) even though cannabis equities continue to face headwinds despite positive fundamental performances.

Canaccord Genuity predicts 26% revenue increase for US cannabis market in 2022, says revenue likely to cross $30B

Is Tilray Stock A Buy, Sell, Or Hold After Recent Earnings?

Tilray, Inc. (TSX:TLRY) (NASDAQ:TLRY) confirmed Tuesday it has been chosen by the Luxembourg Ministry of Health as a supplier of medical cannabis products for the country's recently announced medical cannabis program. The Canadian cannabis giant will supply Luxembourg with a variety of its pharmaceutical-grade and Good Manufacturing Practice-certified medical marijuana products.

Tilray Continues Expanding Its Presence In Europe – Chosen To Supply Luxembourg's Medical Cannabis Program

NEW YORK--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a global pioneer in medical cannabis research, cultivation, production, and distribution, today announced it has been selected by the Luxembourg Ministry of Health as a supplier of Good Manufacturing Practice (GMP) certified medical cannabis products for the country's medical cannabis program. Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts an

Tilray Expands Medical Cannabis Footprint in Europe

Coinbase

Exxon Mobil

Coinbase Global, Inc (NASDAQ: COIN), Tilray, Inc (NASDAQ: TLRY) and Exxon Mobil Corporation (NYSE: XOM) have all settled into bullish flag patterns on the daily chart. The bull flag pattern is created with a sharp rise higher forming the pole, which is then followed by a consolidation pattern that brings the stock lower between a channel with parallel lines.

Coinbase, Tilray, Exxon Stocks Retrace Into This Bullish Pattern: What To Watch For

TLRY stock will lose more money for investors as Tilray's losses mount and the stock gets diluted in the longer term. The post Why It's Worth Betting Against Tilray Stock appeared first on InvestorPlace.

Why It's Worth Betting Against Tilray Stock

Evogene

Flora Growth Corp

Greenlane Holdings

HEXO Corp

High Tide

See Why a Slew of Pot Stocks Made the News This Week

Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.

Insider Cannabis: Time to buy US cannabis stocks - New York's legal gray area - Deals, deals, deals

News from Tilray this week included adding to its management team and signing a new distribution agreement.

Why Tilray Stock Jumped 10% This Week -- While Other Cannabis Names Didn't

TLRY stock is not one for the faint of heart. However, the signs are lining up for another solid rally in Tilray to close out 2021.

The Tilray Roller Coaster Is Set To Climb Once Again

Could Canadian Marijuana Stocks See Upsie In The Fourth Quarter? The post 2 Top Canadian Marijuana Stocks For Your Watchlist In October appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Top Canadian Marijuana Stocks For Your Watchlist In October

OrganiGram Holdings Inc.

MJBizCon 2021 sounded some hopeful notes for marijuana investors.

Why Sundial, Tilray, and OrganiGram Stocks Are Glowing Green Today

Tilray continues to burn through its cash reserves to achieve its improbable $4 billion revenue target. But where does that leave TLRY stock?

Tilray Will Need to Break the Bank to Achieve Its Revenue Target

The company's merger with Aphria closed in May, but investors shouldn't rule out another one in the near future.

Could Another Acquisition Be on the Horizon for Tilray?

Cannabis Producers Could Be Making a Colossal Mistake in Dismissing This Threat

Why Canopy Growth, Tilray, and Hexo Stocks Dropped

NEW YORK & TORONTO--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (Nasdaq:TLRY; TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company and Great North Distributors, Inc. (Great North), Canada's first national sales broker for legalized adult-use cannabis — today announced a signed national brokerage agreement with Tilray Canada Ltd. Under the agreement, Great North will be the exclusive representative for Tilray's complete portfolio of adult-use cannabis products across t

Tilray Signs Distribution Agreement With Great North Distributors for Adult-Use Cannabis Sales Across Canada

Without a clear timeline for cannabis legalization in the United States, TLRY stock is a long-term hold for only the most patient investors. The post Investors Losing Patience as Tilray Waits for Washington To Make Big Move appeared first on InvestorPlace.

Investors Losing Patience as Tilray Waits for Washington To Make Big Move

The stock price of Tilray Inc (NASDAQ: TLRY) increased by over 15% today. This is why it happened.

TLRY Stock: Why It Substantially Increased Today

New York and California have both ruled in favor of pro-cannabis policies. The future is looking green for cannabis stocks.

Cannabis Stocks: Why CGC, TLRY, SNDL, CRON Stocks Are Getting High Today

The Canadian cannabis retailer made a big leadership move and saw its stock rise the most in one day since mid-July.

Why Tilray Stock Climbed More Than 14% Tuesday

News for Tilray Brands Stock (TLRY)